NeoGenomics, Inc. Impairment of Long-Lived Assets Held-for-use
NeoGenomics, Inc. (NEO) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-17
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2024-12-31 was $117.00K.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for the quarter ending 2024-06-30 was $188.00K, a 74.49% decline year-over-year.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for fiscal 2024 was $450.00K, a 73.58% decline from fiscal 2023.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for fiscal 2023 was $1.70M, a 137.19% increase from fiscal 2022.
- NeoGenomics, Inc. impairment of long-lived assets held-for-use for fiscal 2022 was $718.00K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-04-29 | $117.00K derived: sum of 2 quarters · filed 2026-02-17 | $117.00K derived: sum of 3 quarters · filed 2026-02-17 | $305.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $117.00K derived: sum of 2 quarters · filed 2026-02-17 | $305.00K derived: sum of 3 quarters · filed 2026-02-17 | $450.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $188.00K derived: sum of 2 quarters · filed 2024-11-05 | $333.00K 10-Q · filed 2024-11-05 | $333.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $333.00K 10-Q · filed 2024-07-30 | $333.00K derived: sum of 3 quarters · filed 2026-02-17 | $376.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $145.00K 10-Q · filed 2025-04-29 | $145.00K derived: sum of 2 quarters · filed 2026-02-17 | $188.00K derived: sum of 3 quarters · filed 2026-02-17 | $925.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $43.00K derived: sum of 2 quarters · filed 2026-02-17 | $780.00K derived: sum of 3 quarters · filed 2026-02-17 | $1.70M 10-K · filed 2026-02-17 |
| 2023-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $780.00K derived: sum of 2 quarters · filed 2024-11-05 | $1.70M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $737.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $1.66M 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $923.00K 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $718.00K 10-K · filed 2025-02-18 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $3.50M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-13 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-04-18 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |